• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简化版中文简体EORTC QLQ - OPT30对葡萄膜黑色素瘤患者的信度、效度及可接受性

Reliability, validity, and acceptability of the simplified Mandarin Chinese EORTC QLQ-OPT30 for uveal melanoma patients.

作者信息

Huang Yonghui, Cui Panpan, Dong Guangyan, Fan Tongfang

机构信息

Henan Provincial People's Hospital, Henan Provincial Eye Hospital, People's Hospital of Henan University, People's Hospital of Zhenzhou University, Henan Provincial Key Medicine Laboratory of Nursing, Zhengzhou, Henan, China.

Department of Nursing, Henan Provincial Intelligent Nursing and Transformation Engineering Research Center, Henan Provincial Key Medicine Laboratory of Nursing, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.

出版信息

Sci Rep. 2025 Jul 2;15(1):23242. doi: 10.1038/s41598-025-06423-w.

DOI:10.1038/s41598-025-06423-w
PMID:40603401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12222855/
Abstract

This study aimed to translate the EORTC QLQ-OPT30 into Mandarin (Simplified) Chinese and assess its reliability, validity, and acceptability among Chinese uveal melanoma (UM) patients. From January 2023 to June 2024, 60 UM patients from a tertiary hospital in central China were enrolled. The process involved both forward and back translation to develop the Mandarin (Simplified) Chinese version of the EORTC QLQ-OPT30. Statistical analyses were conducted using SPSS 25.0. Reliability was evaluated using Cronbach's α coefficient, and validity was assessed through factor analysis and Pearson correlation tests. Acceptability was determined based on response rate and average completion time. The EORTC QLQ-OPT30 module contains 26 items for all patients, with an additional 4 items for those undergoing treatments other than enucleation. The module measures various aspects such as ocular irritation, visual impairment, headaches, concerns about disease recurrence, appearance issues, functional problems related to vision impairment, reading difficulties, functional issues in the treated eye, and driving problems. The study included 60 patients (45% male, 55% female) with an average age of (55.22 ± 10.02) years. The internal consistency reliability of the multi-item scales was acceptable, with Cronbach's α values ranging from 0.848 to 0.946, except for the AP dimension, which had a lower α value of 0.567. The Mandarin (Simplified) Chinese version of the EORTC QLQ-OPT30 was tested in internal consistency, the split-half, and retest reliability, along with structural, convergent, and discriminant validity; as well as acceptability by its effectiveness, all the above demonstrated good values, making it a valuable tool for measuring health-related quality of life in Chinese UM patients.

摘要

本研究旨在将欧洲癌症研究与治疗组织(EORTC)的QLQ - OPT30翻译成简体中文,并评估其在中国葡萄膜黑色素瘤(UM)患者中的信度、效度和可接受性。2023年1月至2024年6月,招募了来自中国中部一家三级医院的60例UM患者。该过程包括正向和反向翻译,以开发EORTC QLQ - OPT30的简体中文版。使用SPSS 25.0进行统计分析。使用Cronbach's α系数评估信度,并通过因子分析和Pearson相关检验评估效度。根据回复率和平均完成时间确定可接受性。EORTC QLQ - OPT30模块对所有患者包含26个条目,对于接受除眼球摘除术以外治疗的患者额外增加4个条目。该模块测量了眼部刺激、视力损害、头痛、对疾病复发的担忧、外观问题、与视力损害相关的功能问题、阅读困难、患眼的功能问题以及驾驶问题等各个方面。该研究纳入了60例患者(45%为男性,55%为女性),平均年龄为(55.22±10.02)岁。多项目量表的内部一致性信度可接受,Cronbach's α值范围为0.848至0.946,但AP维度的α值较低,为0.567。EORTC QLQ - OPT30的简体中文版在内部一致性、分半和重测信度以及结构效度、收敛效度和区分效度方面进行了测试;并通过其有效性评估了可接受性,上述所有方面均显示出良好的值,使其成为测量中国UM患者健康相关生活质量的有价值工具。

相似文献

1
Reliability, validity, and acceptability of the simplified Mandarin Chinese EORTC QLQ-OPT30 for uveal melanoma patients.简化版中文简体EORTC QLQ - OPT30对葡萄膜黑色素瘤患者的信度、效度及可接受性
Sci Rep. 2025 Jul 2;15(1):23242. doi: 10.1038/s41598-025-06423-w.
2
Translation and validation of the Polish version of the EORTC QLQ-OPT30 module for the assessment of health-related quality of life in patients with uveal melanoma.EORTC QLQ-OPT30 模块波兰语版在评估葡萄膜黑色素瘤患者健康相关生活质量中的翻译和验证。
Eur J Cancer Care (Engl). 2013 Jan;22(1):88-96. doi: 10.1111/ecc.12001. Epub 2012 Sep 12.
3
Validity and reliability of the Flare-OA scale for hip and knee osteoarthritis in a Turkish population: item reduction with Rasch analysis.土耳其人群中用于髋膝关节骨关节炎的Flare-OA量表的效度和信度:基于拉施分析的条目简化
Rheumatol Int. 2025 Jul 3;45(7):163. doi: 10.1007/s00296-025-05914-3.
4
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.使用比美吉珠单抗治疗化脓性汗腺炎的III期BE HEARD I和II试验的汇总数据,对化脓性汗腺炎生活质量(HiSQOL©)问卷进行心理测量学验证和解释阈值分析。
Br J Dermatol. 2025 Jun 20;193(1):93-104. doi: 10.1093/bjd/ljaf067.
5
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
6
Psychometric properties of the Chinese version of the pros and cons of anorexia nervosa (P-CAN-C) scale: a validation study in patients with anorexia nervosa.神经性厌食症利弊中文版量表(P-CAN-C)的心理测量学特性:一项针对神经性厌食症患者的效度研究
J Eat Disord. 2025 Jun 16;13(1):111. doi: 10.1186/s40337-025-01314-x.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
A systematic review of patient-reported outcome measures for advanced skin cancer patients.晚期皮肤癌患者报告结局测量的系统评价。
Arch Dermatol Res. 2023 Aug;315(6):1473-1480. doi: 10.1007/s00403-022-02479-0. Epub 2022 Dec 5.
9
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
10
Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.欧洲癌症研究与治疗组织老年人癌症生活质量问卷模块的制定:EORTC QLQ-ELD15。
Eur J Cancer. 2010 Aug;46(12):2242-52. doi: 10.1016/j.ejca.2010.04.014. Epub 2010 May 23.

本文引用的文献

1
Quality of life among people with eye cancer: a systematic review from 2012 to 2022.眼癌患者的生活质量:2012 年至 2022 年的系统评价。
Health Qual Life Outcomes. 2024 Jan 7;22(1):3. doi: 10.1186/s12955-023-02219-6.
2
Uveal Melanoma Metastasis.葡萄膜黑色素瘤转移
Cancers (Basel). 2021 Nov 13;13(22):5684. doi: 10.3390/cancers13225684.
3
Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma.眼内质子治疗期间的生活质量和治疗相关负担:131 例葡萄膜黑色素瘤患者的前瞻性试验。
Radiat Oncol. 2021 Sep 8;16(1):174. doi: 10.1186/s13014-021-01902-6.
4
Prediction of all-cause mortality from 24 month trajectories in patient-reported psychological, clinical and quality of life outcomes in uveal melanoma patients.预测葡萄膜黑色素瘤患者在 24 个月时间内,患者报告的心理、临床和生活质量结局的全因死亡率。
J Behav Med. 2022 Feb;45(1):115-123. doi: 10.1007/s10865-021-00252-8. Epub 2021 Aug 27.
5
Quality of Life Concerns in Patients with Uveal Melanoma after Initial Diagnosis.葡萄膜黑色素瘤初诊后患者的生活质量问题
Ocul Oncol Pathol. 2020 May;6(3):184-195. doi: 10.1159/000502549. Epub 2019 Sep 27.
6
Quality of Life in Uveal Melanoma Patients in Ireland: A Single-Centre Survey.爱尔兰葡萄膜黑色素瘤患者的生活质量:一项单中心调查
Ocul Oncol Pathol. 2020 Mar;6(2):99-106. doi: 10.1159/000501692. Epub 2019 Aug 22.
7
Patient-Reported Outcomes and Quality of Life after Treatment for Choroidal Melanoma.脉络膜黑色素瘤治疗后的患者报告结局与生活质量
Ocul Oncol Pathol. 2019 Oct;5(6):402-411. doi: 10.1159/000496927. Epub 2019 Mar 25.
8
Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study.眼葡萄膜黑色素瘤眼摘出术与质子束放疗后患者报告结局的比较:一项 2 年队列研究。
Eye (Lond). 2019 Sep;33(9):1478-1484. doi: 10.1038/s41433-019-0440-0. Epub 2019 Apr 15.
9
Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017.2007-2017 年美国单侧视网膜母细胞瘤初次眼球摘除术后的转移率和死亡率。
Br J Ophthalmol. 2019 Sep;103(9):1272-1277. doi: 10.1136/bjophthalmol-2018-312915. Epub 2018 Oct 25.
10
Evaluation of methods used for estimating content validity.评价用于估计内容效度的方法。
Res Social Adm Pharm. 2019 Feb;15(2):214-221. doi: 10.1016/j.sapharm.2018.03.066. Epub 2018 Mar 27.